Now showing items 1-2 of 2

  • The european primary care monitor : structure, process and outcome indicators 

    Hasvold, Toralf; Kringos, Dionne S; Boerma, W; Bourgueil, Yann; Cartier, Thomas; Hutchinson, A; Lember, M; Oleszczyk, M; Pavlic, D; Svab, I; Tedeschi, P; Wilson, Andrew; Windak, A; Dedeu, T; Wilm, S (Journal article; Tidsskriftartikkel; Peer reviewed, 2010)
  • Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels 

    Parikh, H; Wang, ZM; Pettigrew, KA; Jia, JP; Daugherty, S; Yeager, M; Jacobs, KB; Hutchinson, A; Burdett, L; Cullen, M; Qi, LQ; Boland, J; Collins, I; Albert, TJ; Vatten, Lars Johan; Hveem, Kristian; Njølstad, Inger; Cancel-Tassin, G; Cussenot, O; Valeri, A; Virtamo, J; Thun, MJ; Feigelson, HS; Diver, WR; Chatterjee, N; Thomas, G; Albanes, D; Chanock, SJ; Hunter, DJ; Hoover, R; Hayes, RB; Berndt, SI; Sampson, J; Amundadottir, L (Journal article; Tidsskriftartikkel; Peer reviewed, 2011)
    Measurements of serum prostate-specific antigen (PSA) protein levels form the basis for a widely used test to screen men for prostate cancer. Germline variants in the gene that encodes the PSA protein (KLK3) have been shown ...